Research Article

Association of HER1 and HER2 Gene Variants in the Predisposition of Colorectal Cancer

Table 2

HER1 and HER2 receptor SNPs’ genotype and allele frequencies in colorectal cancer cases and the control population.

SNP IDGenotypeControls, n (frequency)Colorectal cancer, n (frequency)OR (95% CI)χ2 value value

rs763317 HER1AA43 (0.29)40 (0.29)Ref
GA82 (0.55)73 (0.52)0.957 (0.561–1.632)0.030.87181
GG24 (0.16)27 (0.19)1.209 (0.602–2.431)0.280.59350
Allele
A168 (0.56)153 (0.55)Ref
G130 (0.44)127 (0.45)1.073 (0.773–1.490)0.180.67521

rs3752651 HER1TT119 (0.73)102 (0.71)Ref
CT38 (0.23)41 (0.29)1.259 (0.752–2.106)0.770.38023
CC6 (0.04)0 (0)0.090 (0.005–1.611)5.030.02493
Allele
T276 (0.85)245 (0.86)Ref
C50 (0.15)41 (0.14)0.924 (0.591–1.445)0.120.72819

rs1058808 HER2GG62 (0.39)44 (0.32)Ref
CG81 (0.51)71 (0.51)1.235 (0.749–2.038)0.680.40828
CC17 (0.11)24 (0.17)1.989 (0.957–4.135)3.450.06333
Allele
G205 (0.64)159 (0.57)Ref
C115 (0.36)119 (0.43)1.334 (0.960–1.855)2.950.08608

rs1136201 HER2AA123 (0.76)120 (0.85)Ref
AG37 (0.23)21 (0.15)0.582 (0.322–1.051)3.260.07079
GG2 (0.01)0 (0)0.205 (0.010–4.314)1.940.16413
Allele
A283 (0.87)261 (0.93)Ref
G41 (0.13)21 (0.07)0.555 (0.320–0.965)4.450.03486

OR 95% CI, odds ratio and 95% confidence interval. was considered significant and are depicted in bold.